Public Reporting A2024
As required by CMS, the information on this webpage contains our Public Reporting informationACO Name and Location:
Accountable Care Organization of Pennsylvania, LLC (Delaware Valley ACO)
Previous Names: N/A
259 North Radnor Chester Road
Suite 290
Radnor, Pennsylvania 19087
ACO Primary Contact
Primary Contact Name | Jeanette Flood |
Primary Contact Phone Number | 610-225-6210 |
Primary Contact Email Address | floodj@dvaco.org |
Organizational Information
ACO Participants:
ACO Participants | ACO Participant in Joint Venture (Enter Y or N) |
Abington Memorial Hospital (Abington, Abington-Lansdale and Employed Physicians) | N |
ABS Medicine LLC (Simpson Allergy & Asthma) | N |
Aria Health | N |
Aria Health Orthopaedics | N |
Aria Health Physician Services | N |
Associates in Pastic Surgery, Inc | N |
Balmont Family Practice | N |
Barry Burkhardt | N |
Broker, Cramer & Swanson ENT, PC (ENT and Allergy Specialists) | N |
CSB Medicine, LLC (Narberth Allergy and Asthma) | N |
Daniel C. Lazowick, D.O., LLC | N |
Deebeanne M Tavani DO PhD PC | N |
Delaware Valley I.D. Associates, P.C. | N |
Devon Family Practice LLP | N |
Edward Stankiewicz | N |
Endeavor Health LLC | N |
Geoffrey W. Temple Family Medical Associates, P.C. | N |
Gerard Miller | N |
Great Valley Medical Associates PC | N |
Great Valley Neurological Associates LLC | N |
Jefferson Medical Care, PC | N |
Jefferson University Physicians | N |
Jefferson University Physicians of New Jersey PC | N |
Jefferson University Radiology Associates LLC | N |
Jon Yardney, M.D. LLC | N |
Joseph LaBricciosa DO PC | N |
Lawrence I Katin MD PC | N |
Lower Merion Family Medicine PC | N |
Lower Merion Rehabilitation | N |
Magee Rehabilitation Hospital | N |
Main Line Allergy, L.L.P. | N |
Main Line Emergency Med Associates LLC | N |
Main Line Health HomeCare and Hospice | N |
Main Line Health Imaging, LP | N |
Main Line HealthCare | N |
Main Line Hospitals, Inc. (Bryn Mawr Hospital, Bryn Mawr Rehabilitation Hospital, Lankenau Medical Center, Mirmont Treatment Center, Paoli Hospital, Riddle Hospital) | Y |
Main Line Institute of Plastic Surgery Inc | N |
Main Line Pathology Associates, PC | N |
Main Line Radiation Oncology PC | N |
Mazzoni Center | N |
Medical Associates of the Main Line, PC | N |
Methodist Associates in Healthcare, Inc. | N |
Methodist Associates in Healthcare Of New Jersey, P.C. | N |
Mukesh Patel | N |
Paoli Family Medicine | N |
Peter Christie | N |
Philadelphia Family Medicine Assoc P.C. | N |
Philadelphia Health Associates – Adult Medicine, P.C. | N |
Pulmonology Associates Inc | N |
Radiology Associates of the Main Line PC | N |
Radnor Family Practice Professional Limited Liability Company | N |
Rehabilitation Associates of the Main Line, P.C. | N |
Rheumatology Medical Specialists PC | N |
Riddle Memorial Hospital (a Main Line Health Hospital) | Y |
Ross Podell, M.D., P.C. | N |
Roy M Lerman MD PC (Main Line Spine) | N |
Segal Aaronson Pulmonary Associates PC (Acquired by Jefferson University Physicians) | N |
Smith Medicine, PC | N |
Suburban Endocrinology Associates, PC | N |
Thomas Jefferson University Hospitals, Inc. (Jefferson Hospital for Neuroscience, Methodist Hospital, Thomas Jefferson University Hospital) | Y |
United Anesthesia Services PC | N |
William Greer, M.D., P.C. | N |
William J. Lewis, M.D., P.C. (Main Line Ear, Nose and Throat/Head and Neck Surgery) | N |
William R. Schetman, M.D., LLC | N |
ACO Governing Body:
Member | Member’s Voting Power– Expressed as a percentage or number | Membership Type | ACO Participant Legal Business Name/DBA, if Applicable | ||
Last Name | First Name | Title/Position | |||
Gleason, M.D. | Johnathan | Co-Chair | 1 | ACO Participant Representative | Thomas Jefferson University Hospitals, Inc. |
Mankin, M.D. | Eric | Co-Chair | 1 | ACO Participant Representative | Main Line Health Hospitals, Inc. |
Behan, M.D. | Katherine | 1 | ACO Participant Representative | Thomas Jefferson University Hospitals, Inc. | |
Gorman | Kirk | 1 | Medicare Beneficiary Representative | N/A | |
Greer, M.D. | William | 1 | ACO Participant Representative | William Greer, M.D., P.C. | |
Angelo, M.D. | Mark | 1 | Other: ACO Acting President & Chief Executive Officer | N/A | |
Stallkamp, M.D. | Jonathan | 1 | ACO Participant Representative | Main Line Hospitals Inc. | |
Sweigard, M.D. | Keith | 1 | ACO Participant Representative | Abington Memorial Hospital |
Key ACO Clinical and Administrative Leadership:
ACO Executive (Acting President & CEO) | Mark Angelo, M.D., MHA, FACP |
Medical Director (Chief Clinical Officer)Mark Angelo, M.D., MHA, FACP | Mark Angelo, M.D., MHA, FACP |
Compliance Officer | Christopher Jackson |
Quality Assurance/Improvement Officer (Director, Quality Improvement) | Virginia Bodycot, BSN, RN |
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name and Position |
Audit and Finance Committee | Michael J. Buongiorno (Chair) |
Clinical Integration Committee | Katherine Behan, M.D. (Co-Chair) Eric Mankin, MD (Co-Chair) |
Types of ACO Participants, or Combinations of Participants, That Formed the ACO:
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2020, $0
- Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $0
- First Agreement Period
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $6,567,267
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2020
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2019
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: 15%
- Proportion invested in redesigned care processes/resources: 15%
- Proportion of distribution to ACO participants: 70%
- Performance Year 2016
Quality Performance Results
2020 Quality Performance Results:
ACO Quality Measure Number | Measure Name | Rate | ACO Mean |
ACO-1 | CAHPS: Getting Timely Care, Appointments, and Information | N/A | N/A |
ACO-2 | CAHPS: How Well Your Providers Communicate | N/A | N/A |
ACO-3 | CAHPS: Patients’ Rating of Provider | N/A | N/A |
ACO-4 | CAHPS: Access to Specialists | N/A | N/A |
ACO-5 | CAHPS: Health Promotion and Education | N/A | N/A |
ACO-6 | CAHPS: Shared Decision Making | N/A | N/A |
ACO-7 | CAHPS: Health Status/Functional Status | N/A | N/A |
ACO-34 | CAHPS: Stewardship of Patient Resources | N/A | N/A |
ACO-45 | CAHPS: Courteous and Helpful Office Staff | N/A | N/A |
ACO-46 | CAHPS: Care Coordination | N/A | N/A |
ACO-8 | Risk Standardized, All Condition Readmission | N/A | N/A |
ACO-38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions | N/A | N/A |
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 0.94 | 0.95 |
ACO-13 | Falls: Screening for Future Fall Risk | 91.19 | 84.97 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 85.56 | 76.03 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 68.75 | 81.67 |
ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 63.79 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 71.43 | 72.59 |
ACO-20 | Breast Cancer Screening | 80.24 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 81.74 | 83.37 |
ACO-27 | Diabetes: Hemoglobin A1c Poor Control (>9%) | 13.10 | 14.70 |
ACO-28 | Controlling High Blood Pressure | 71.05 | 72.87 |
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.
Contact Information
Phone 610-225-6295
Toll Free Number 855-761-9345
TTY# 610-225-6275
Compliance Line 610-225-6211
Email dvacomail@dvaco.org
Business Hours 9-5pm